Erlotinib and febrile neutropenia Patient Reports February 11, 2012

Erlotinib Side Effects Report #5156795-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 30, 2006. Female patient, 46 years of age, weighting 136.0 lb, was diagnosed with sarcoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with TIPIFARNIB, FENTANYL, GABAPENTIN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN. Patient recovered.

Erlotinib Side Effects Report #6108681-1
Erlotinib side effect was reported by a Physician from SPAIN on Feb 18, 2009. Female patient, 70 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, mucosal inflammation. Erlotinib dosage: (100 MG), ORAL. During the same period patient was treated with GEMCITABINE, INSULINA, VALSARTAN, HIDROCLOROTIAZIDA, OMEPRAZOLE, LOPERMIDA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5711267-1
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on Mar 31, 2008. Male patient, 40 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, cholangitis, dyspnoea, febrile neutropenia, hepatitis , jaundice cholestatic, night sweats. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, GEMCITABINE, PYRIDOXINE, RAMOSETRON HYDROCHLORIDE, NOVOLIN N, METOCLOPRAMIDE, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5736886-8
Erlotinib side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Apr 23, 2008. Male patient, 40 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, cholangitis, dyspnoea, febrile neutropenia, hepatitis , lymphocyte count decreased, monocyte count decreased, night sweats, platelet count decreased. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, GEMCITABINE, PYRIDOXINE, RAMOSETRON, NOVOLIN N, METOCLOPRAMIDE, OXYCODONE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5766192-7
Erlotinib side effect was reported by a Physician from KOREA, REPUBLIC OF on May 19, 2008. Male patient, 40 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, eastern cooperative oncology group performance status worsened, febrile neutropenia, haematocrit decreased, hepatitis cholestatic, jaundice cholestatic, laboratory test abnormal, lymphocyte count decreased. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with CAPECITABINE, GEMCITABINE, PYRIDOXINE, RAMOSETRON, NOVOLIN N, METOCLOPRAMIDE, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5819962-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 11, 2008. Female patient, 51 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: culture urine positive, febrile neutropenia, hyperbilirubinaemia, klebsiella infection, urinary tract infection . Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, VICODIN, LASIX, PROZAC, PROTONIX, FEMARA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6075362-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 26, 2009. Male patient, 76 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, platelet count decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, INSULIN, EXELON, ASPIRIN, GLUCOTROL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6083736-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 10, 2009. Male patient, 76 years of age, weighting 195.3 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal haemorrhage, haemoglobin decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5916942-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2008. Male patient, 62 years of age, weighting 149.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypovolaemia, oesophagitis, platelet count decreased, white blood cell count decreased. Erlotinib dosage: (100 MG, QD) , ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #6063552-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, febrile neutropenia, penis disorder , vomiting, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6083750-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 03, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, dysphagia, febrile neutropenia, penis disorder , vomiting, white blood cell count decreased. Erlotinib dosage: 100 MG, DAYS 1-42, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ROXICET, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5844660-7
Erlotinib side effect was reported by a Health Professional from BELGIUM on Aug 04, 2008. Female patient, 65 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, febrile neutropenia. Erlotinib dosage: (150 MG, QD). During the same period patient was treated with PRAZEPAM, SPIRIVA, SYMBICORT, LANSOPRAZOLE, PRIMPERAN, BRUFEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5875380-0
Erlotinib side effect was reported by a Physician from BELGIUM on Aug 21, 2008. Female patient, 65 years of age, weighting 152.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cough, dyspnoea, febrile neutropenia, hepatic function abnormal. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with CEFUROXIME AXETIL, PRAZEPAM, TIOTROPIUM, SYMBICORT, LANSOPRAZOLE, PRIMPERAN, IBUPROFEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5332130-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 03, 2007. Female patient, 61 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatinine increased, blood phosphorus increased, diarrhoea, febrile neutropenia, haemoglobin decreased, hypokalaemia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5670021-X
Erlotinib side effect was reported by a Health Professional from HUNGARY on Feb 27, 2008. Male patient, 49 years of age, weighting 249.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , dermatitis acneiform, fatigue, febrile neutropenia, headache , pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PEMETREXED, TIOTROPIUM BROMIDE, FOLIC ACID, VITAMIN B12, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5320159-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 18, 2007. Male patient, 63 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, febrile neutropenia, myalgia, nuclear magnetic resonance imaging abnormal, platelet count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5351039-3
Erlotinib side effect was reported by a Physician from UNITED STATES on May 21, 2007. Male patient, 63 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, febrile neutropenia, myalgia. Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5224445-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 12, 2007. Male patient, 52 years of age, weighting 220.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, pain . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5245856-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 31, 2007. Male patient, 52 years of age, weighting 220.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, pain , white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, ALBUTEROL, CELEXA, SEROQUEL, PEPCID. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5174252-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 20, 2006. Female patient, 70 years of age, weighting 145.9 lb, was diagnosed with neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, cough, fatigue, febrile neutropenia, haematocrit decreased, platelet count decreased, vomiting. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, SENOKOT, ATIVAN, TYLENOL, LEVAQUIN, MUCINEX, GUAIFENESIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5450729-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 24, 2007. Female patient, 70 years of age, weighting 145.9 lb, was diagnosed with neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, asthenia, cough, febrile neutropenia, haematocrit decreased, platelet count decreased, vomiting, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, SENOKOT, ATIVAN, ACETAMINOPHEN, LEVAQUIN, MUCINEX, GUAIFENESIN, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5797515-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 13, 2008. Male patient, 48 years of age, was diagnosed with myelodysplastic syndrome and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with OXYCONTIN, OXYCODONE, VALTREX, CYMBALTA, AMBIEN, ALLOPURINOL, OMEPRAZOLE, ATIVAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5735829-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 08, 2008. Male patient, weighting 143.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Erlotinib dosage: 150MG DAILY PO. Patient recovered.

Erlotinib Side Effects Report #6140724-1
Erlotinib side effect was reported by a Physician from GREECE on Mar 16, 2009. Female patient, 69 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DOCETAXEL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5757718-8
Erlotinib side effect was reported by a Consumer or non-health professional from SPAIN on May 14, 2008. Male patient, 49 years of age, weighting 169.8 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with PEMETREXED. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5913786-1
Erlotinib side effect was reported by a Consumer or non-health professional from SPAIN on Sept 23, 2008. Male patient, 49 years of age, weighting 169.8 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, infection . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PEMETREXED. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6121293-9
Erlotinib side effect was reported by a Consumer or non-health professional from SPAIN on Feb 27, 2009. Male patient, 49 years of age, weighting 169.8 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PEMETREXED, VITAMIN B12, FOLIC ACID, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5836184-8
Erlotinib side effect was reported by a Physician from UNITED STATES on July 22, 2008. Female patient, 68 years of age, weighting 120.6 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5401046-7
Erlotinib side effect was reported by a Physician from UNITED STATES on July 11, 2007. Male patient, 67 years of age, weighting 159.2 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5407965-X
Erlotinib side effect was reported by a Physician from UNITED STATES on July 20, 2007. Male patient, 67 years of age, weighting 159.2 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, dermatitis acneiform, fatigue, febrile neutropenia, limb discomfort, viral infection . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5074815-3
Erlotinib side effect was reported by a Physician from UNITED STATES on May 18, 2006. Male patient, 54 years of age, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diverticulum intestinal, electrolyte imbalance, febrile neutropenia, large intestine perforation, pancytopenia, sepsis . Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, SULFAMETHOXAZOLE, LEVAQUIN, OLANZAPINE. Patient died on 02/13/2006.

Erlotinib Side Effects Report #4933916-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 54 years of age, weighting 148.6 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: colostomy, diverticular perforation, enterococcal infection, febrile neutropenia, haematocrit decreased, haemoglobin decreased, mental status changes, platelet count decreased, pseudomonas infection. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, ESOMEPRAZOLE, LEXAPRO, KYTRIL, LEVAQUIN, ZYPREXA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5020579-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2006. Male patient, 54 years of age, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diverticular perforation, diverticulum intestinal, febrile neutropenia, gastrointestinal perforation, pancytopenia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, SULFAMETHOXAZOLE, LEVAQUIN, OLANZAPINE. Patient died on 02/13/2006.

Erlotinib Side Effects Report #5081569-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 24, 2006. Female patient, 66 years of age, weighting 82.01 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, blood pressure decreased, febrile neutropenia, palpitations. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5101976-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 24, 2006. Female patient, 66 years of age, weighting 82.01 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, blood pressure decreased, febrile neutropenia, heart rate increased, palpitations. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5277741-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, febrile neutropenia, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5305173-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, dehydration, febrile neutropenia, hypertension, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5351038-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 21, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, chest pain , dehydration, febrile neutropenia, hypertension, nausea . Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5074055-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 02, 2006. Female patient, 66 years of age, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arrhythmia , febrile neutropenia. Erlotinib dosage: unknown. During the same period patient was treated with AVASTIN, FOLINIC ACID, FLUOROURACIL, OXALIPLATIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5491351-0
Erlotinib side effect was reported by a Health Professional from SPAIN on Oct 02, 2007. Female patient, 58 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Erlotinib dosage: 150 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PEMETREXED. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5567366-0
Erlotinib side effect was reported by a Health Professional from SPAIN on Nov 30, 2007. Female patient, 58 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia. Erlotinib dosage: (150 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PEMETREXED, DEXAMETHASONE, FOLIC ACID, VITAMIN B12. Patient was hospitalized. Patient recovered.